Postmenopausal women who follow a low-fat diet have 24 percent less chance of a recurrence of breast cancer

According to a U.S. study, postmenopausal women who follow a low-fat diet have 24 percent less chance of a recurrence of breast cancer compared with women on a standard diet.

The study by Rowan T. Chlebowski and colleagues at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, involved 2,437 women aged 48 to 79 who were diagnosed with early stage breast cancer and were treated at several medical centers. All the women had the standard treatments such as surgery, radiation therapy, and chemotherapy and or tamoxifen therapy.

Within a year of the initial diagnosis the women were divided into two groups, one group was put on a low-fat diet and the other on a standard diet. The low-fat diet group was also given nutritional advice.

Women on the low-fat diet ate an average of 33.3 grams of dietary fat each day compared with 51.3 grams of fat for another group, and lost an average of four pounds each.

It was found that during a five-year follow-up, 9.8 percent of the women on the low-fat diet had a recurrence compared with 12.4 percent for those who were on the standard diet.

Those women in the low-fat diet group with estrogen receptor-negative breast cancer also had a 42 percent lower risk recurrence compared with the women on the standard diet.

Though it is unclear how a low-fat diet can help reduce the risk of breast cancer recurrence, some scientists theorise that it may be something other than the low intake of dietary fat.

A low-fat diet consists of more fruits and vegetables, which may be more a important factor than low-intake of fat in the reduction of risk.

The results, however they are interpreted, appear to show that women with estrogen receptor-negative breast cancer can greatly benefit from a low-fat diet.

The study was presented on May 16 at the annual meeting of the American Society of Clinical Oncology in Orlando, Florida.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients